USA Healthcare Market Outlook to 2028

USA Healthcare Market Overview

The USA Healthcare Market was valued at USD 4.9 trillion. The market continues to be the largest in the world, driven by factors such as increasing government spending, technological innovations in medical equipment and pharmaceuticals, and a rising aging population.

Major players in the market are United Health Group, CVS Health, Anthem, Kaiser Permanente, and Pfizer. These companies dominate various sectors such as health insurance, pharmaceuticals, and healthcare services, benefiting from established infrastructure, brand trust, and comprehensive networks.

In 2023, the acquisition of Signify Health by CVS Health for $8 billion. This acquisition represents a strategic move by CVS to strengthen its home health services, positioning the company to tap into the growing demand for in-home healthcare solutions.

California dominates the market, driven by a combination of its large population and advanced healthcare infrastructure. In 2020, Californias healthcare expenditure was $405 billion, the highest of any U.S. state. The state's focus on innovation, research, and technology in healthcare, particularly in cities like Los Angeles and San Francisco, contributes to its dominance.

USA Healthcare Market Segmentation

The market is segmented into various factors service, provider, and region.

By Service Type: The market is segmented by service into hospital services, outpatient services, and long-term care services. Hospital services held the largest market by the increasing number of hospital admissions and complex surgeries requiring specialized care.

By Provider Type: The market is segmented by provider into public hospitals, private hospitals, and specialty care centers. Private hospitals lead due to their investment in cutting-edge technology, offering more specialized services and shorter waiting times compared to public hospitals.

By Region: The market is segmented by region into North, South, East, and West. The West region is the largest market due to advanced healthcare facilities and technological infrastructure, especially in California.

USA Healthcare Market Competitive Landscape

Company

Established

Headquarters

United Health Group

1977

Minnesota

CVS Health

1963

Rhode Island

Anthem

2004

Indiana

Kaiser Permanente

1945

California

Pfizer

1849

New York

Anthem: In 2024, Anthem announced a major partnership with Google Cloud to enhance its AI capabilities in healthcare. The collaboration focuses on creating a synthetic data platform intended to improve the detection of fraudulent claims and facilitate personalized care for patients. This initiative aims to generate approximately 1.5 to 2 petabytes of synthetic data, which will be used to train AI algorithms for better healthcare insights and interventions

Pfizer: The FDA has approved Pfizer's gene therapy, Beqvez, for treating hemophilia B, a rare genetic disorder affecting about 7,000 U.S. patients. This one-time treatment enables patients to produce their own factor IX, reducing bleeding episodes. Beqvez's pricing remains undisclosed, but competition exists with CSL Behring's Hemgenix, priced at $3.5 million.

USA Healthcare Market Analysis

Market Growth Drivers

Increased Government Healthcare Spending: Government expenditure on healthcare is a substantial factor in driving market growth. In 2024, the U.S. government spent $4.8 trillion in 2023 for healthcare sector. This allocation represents a continued emphasis on ensuring healthcare access for low-income and elderly individuals, while also improving the overall healthcare systems efficiency. The rising government focus on healthcare affordability and expansion of public healthcare programs.

Rising Prevalence of Chronic Diseases: The increasing prevalence of chronic diseases, such as diabetes and cardiovascular conditions, is another key driver for the market. In 2023, over 38.4 million Americans were living with diabetes. The need for ongoing medical treatment, hospitalizations, and management of these conditions places significant demand on healthcare providers, pharmaceuticals, and medical devices, which in turn drives market expansion.

Digital Healthcare Expansion: Digital healthcare services, particularly telemedicine, have experienced rapid growth. In 2024, telemedicine visits are raised in the U.S., a trend that has grown since the pandemic. The rise in telemedicine is being fueled by consumer demand for convenience and accessibility, as well as advancements in healthcare IT infrastructure.

Market Challenges

Healthcare Workforce Shortages: The U.S. healthcare sector is facing a critical shortage of healthcare professionals. In 2023, the country reported a shortfall of nurses, along with deficits in primary care physicians and other medical specialists. The aging healthcare workforce, coupled with the increasing demand for medical services, exacerbates the problem.

Rising Costs of Medical Treatments: Healthcare costs in the U.S. have continued to increase, with the average annual per capita healthcare expenditure exceeding in 2023. The escalating costs of hospital stays, medical procedures, and prescription drugs are major challenges to the healthcare systems affordability and accessibility.

Government Initiatives

Healthcare Affordability Act (2023): The U.S. government is advancing the Health Care Affordability Act, aimed at making health insurance more accessible. This initiative seeks to permanently enhance premium tax credits, ensuring no American pays over 8.5% of their income on premiums, potentially benefiting over 16 million individuals by 2024 improving access to healthcare services while addressing the issue of rising healthcare costs.

Pharmaceutical Innovation Funding (2023): In fiscal year 2023, the National Institutes of Health (NIH), which is the largest public funder of biomedical research in the U.S., allocated around $18.9 billion specifically for clinical research funding. The funding is expected to result in the development of cutting-edge treatments, including gene therapies for rare diseases, by 2028, driving growth in the biotech and pharmaceutical sectors.

USA Healthcare Market Future Outlook

The future trends in the USA healthcare market include the increased integration of AI, the growth of personalized medicine, expanded telehealth services, and advancements in home healthcare services for the elderly and chronically ill.

Future Market Trends

AI Integration in Healthcare: Over the next five years, artificial intelligence (AI) is expected to revolutionize the U.S. healthcare market by transforming diagnostics and treatment planning. By 2028, AI-based tools will assist in diagnosing diseases such as cancer and neurological disorders, leading to more accurate and timely interventions. AI-driven innovations in areas like predictive analytics are forecasted to generate significant improvements in patient outcomes, with adopting AI systems by 2028.

Personalized Medicine Growth: Personalized medicine, driven by advances in genomics and biotechnology, is projected to see significant growth in the U.S. healthcare industry through 2028. By leveraging patients genetic information, personalized treatments will become more common, particularly in oncology and rare disease management. This trend is expected to improve treatment efficacy and reduce adverse effects, with over 10 million patients anticipated to benefit from personalized medicine by 2028.
Please Note: It will take 5-7 business days to complete the report upon order confirmation